Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
132 participants
OBSERVATIONAL
2014-01-31
2014-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Diabetic Macular Edema Severity at Diagnosis
NCT00886392
OCT-angiography in Diabetic Patients
NCT02870803
Reduction of Foveal Sensitivity in Eyes With Diabetic Macular Edema
NCT01824862
Home Monitoring of Diabetic Macular Edema
NCT05223569
A Systematic Study of Retinal Structure and Function in Diabetic Macular Oedema
NCT02876393
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Contrast Sensitivity
Determine changes in contrast sensitivity frequences and visual function (visual acuity) after one month of treatment photocoagulation in macular edema
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 40-60 YEARS OLD
* ANY GENDER
* VISUAL ACUITY \>0.25 IN DECIMAL EQUIVALENT,
Exclusion Criteria
* PATIENTS WITH CONTACT LENSES
* PATIENTS WITH REFRACTIVE ERROR \>6.00DP
* PATIENTS WITH PREVIOUS OCULAR SURGERY
40 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospital Juarez de Mexico
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dulce Milagros Razo Blanco Hernández
MEDICAL RESEARCHER
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
DULCE MI RAZO BLANCO HERNANDEZ, MD
Role: PRINCIPAL_INVESTIGATOR
Hospital Juarez de Mexico
SURISADAI SERAFIN SOLIS, MSc
Role: STUDY_CHAIR
INSTITUTO POLITECNICO NACIONAL
LOURDES CA ORTEGA LUNA, MSc
Role: STUDY_CHAIR
INSTITUTO POLITECNICO NACIONAL
VIRGILIO LIMA GOMEZ, MD, MSc
Role: STUDY_DIRECTOR
Hospital Juarez de Mexico
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital Juarez de Mexico
Mexico City, Mexico City, Mexico
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HJM2295/14R
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.